Elyria-based Surgical Theater has received FDA approval of their Selman Surgery Rehearsal Platform (SRP), making it the only patented and approved platform for cerebral and spine pre-surgery simulation.
Using standard scanned images from the patient, the SRP generates 3-D patient specific and accurate models showing the interaction between life-like tissue and surgical instruments. The animated tissue “responds” to actions taken by the surgeon, enabling accurate pre-surgery planning and rehearsal. The unique software utilizes flight simulator technology to permit the remote connection of multiple SRPs. Participants anywhere in the world can simultaneously work together, practice the same case with real-time feedback, and collaborate on surgery planning.
“Receiving FDA approval is confirmation of the innovative technology that our company has worked so hard to create over the last several years and the beginning of what we believe will be improved patient outcomes for cerebral and spine surgery patients,” said Surgical Theater President & CEO Moty Avisar.
“A surgeon’s main priority is to provide the best treatment for their patients,” Avisar added. “The SRP offers a one-of-a-kind opportunity through pre-procedure rehearsal to reduce risk and maximize the chance for superior outcomes.”
Surgical Theater launched SRP late last year after receiving their first broad patent approval and submitting their application to the FDA. Early this year, the company completed the first sale of its groundbreaking technology to University Hospitals Case Medical Center in Cleveland. Physicians at the medical center have been instrumental in the company’s development.
“It is widely accepted that ‘purposeful practice makes perfect’ and having a tool like the SRP provides that opportunity and will help ensure improved patient safety and outcomes,” says Dr. Warren Selman, chairman, Department of Neurological Surgery, UH Case Medical Center and Case Western Reserve University School of Medicine. Dr. Selman is a co-originator of the Platform’s development.